TD Asset Management
LYEL icon

TD Asset Management’s Lyell Immunopharma LYEL Stock Holding History

TD Asset Management’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,232
Closed -$444K – 1269
2025
Q2 		$444K Hold
50,232
– – ﹤0.01% 1142
2025
Q1 		$540K Hold
50,232
– – ﹤0.01% 1137
2024
Q4 		$643K Hold
50,232
– – ﹤0.01% 1162
2024
Q3 		$1.52M Hold
50,232
– – ﹤0.01% 1113
2024
Q2 		$1.46M Buy
50,232
+2,040
+4% +$97.1K ﹤0.01% 1084
2024
Q1 		$2.15M Buy
48,192
+2,380
+5% +$102K ﹤0.01% 996
2023
Q4 		$1.78M Hold
45,812
– – ﹤0.01% 1047
2023
Q3 		$1.35M Buy
45,812
+24,216
+112% +$1.15M ﹤0.01% 1068
2023
Q2 		$1.37M Buy
21,596
+12,612
+140% +$698K ﹤0.01% 1057
2023
Q1 		$424K Hold
8,984
– – ﹤0.01% 1298
2022
Q4 		$624K Hold
8,984
– – ﹤0.01% 1240
2022
Q3 		$1.33M Hold
8,984
– – ﹤0.01% 1113
2022
Q2 		$1.17M Hold
8,984
– – ﹤0.01% 1152
2022
Q1 		$907K Buy
8,984
+550
+7% +$66.6K ﹤0.01% 1250
2021
Q4 		$1.31M Buy
8,434
+2,802
+50% +$625K ﹤0.01% 1231
2021
Q3 		$1.67M Buy
5,632
+1,308
+30% +$392K ﹤0.01% 1135
2021
Q2 		$1.25M Buy
+4,324
New +$1.42M ﹤0.01% 1210

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

TD Asset Management's LYEL Position: Q3 2025 in Review

TD Asset Management sold out of Lyell Immunopharma (LYEL) in Q3 2025, closing a stake of 50,232 shares — an estimated $444K sold.

TD Asset Management first reported a position in LYEL in Q2 2021 and held it in 17 quarters. The position peaked at $2.15M in Q1 2024. 59 funds tracked by Wall St. Rank hold LYEL as of Q3 2025.

  • TD Asset Management reported no remaining Lyell Immunopharma position as of Q3 2025 after selling out during the quarter.
  • TD Asset Management sold 50,232 Lyell Immunopharma shares in Q3 2025, an estimated $444K.
  • TD Asset Management first reported a position in Lyell Immunopharma in Q2 2021 and held it in 17 quarters.
  • TD Asset Management's Lyell Immunopharma position peaked at $2.15M in Q1 2024.
  • 59 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2025.

Based on TD Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.